Have a personal or library account? Click to login

References

  1. 1Schneider SA, Bird T. Huntington’s Disease, Huntington’s Disease Look-Alikes, and Benign Hereditary Chorea: What’s New? Mov Disord Clin Pract. 2016; 3(4): 342354. DOI: 10.1002/mdc3.12312
  2. 2Walker RH. Chorea. Continuum (Minneap Minn). 2013; 19. (5 Movement Disorders): 124263. DOI: 10.1212/01.CON.0000436155.46909.c3
  3. 3Piccolo I, Defanti CA, Soliveri P, Volontè MA, Cislaghi G, Girotti F. Cause and course in a series of patients with sporadic chorea. J Neurol. 2003; 250(4): 42935. DOI: 10.1007/s00415-003-1010-7
  4. 4Walker RH. Update on the Non-Huntington’s Disease Choreas with Comments on the Current Nomenclature. Tremor Other Hyperkinet Mov (N Y). 2012; 2: tre-02-49-211-1. DOI: 10.5334/tohm.122
  5. 5Martino D, Stamelou M, Bhatia KP. The differential diagnosis of Huntington’s disease-like syndromes: ‘red flags’ for the clinician. J Neurol Neurosurg Psychiatry. 2013; 84(6): 6506. DOI: 10.1136/jnnp-2012-302532
  6. 6Mencacci NE, Carecchio M. Recent advances in genetics of chorea. Curr Opin Neurol. 2016; 29(4): 48695. DOI: 10.1097/WCO.0000000000000352
  7. 7Walker RH. The non-Huntington disease choreas: Five new things. Neurol Clin Pract. 2016; 6(2): 150156. DOI: 10.1212/CPJ.0000000000000236
  8. 8Martinez-Ramirez D, Walker RH, Rodríguez-Violante M, Gatto EM; Review of Hereditary and Acquired Rare Choreas. Rare Movement Disorders Study Group of International Parkinson’s Disease. Tremor Other Hyperkinet Mov (N Y). 2020 Aug 6; 10: 24. DOI: 10.5334/tohm.548
  9. 9Bovenzi R, Conti M, Cerroni R, Pierantozzi M, Stefani A, Pisani A, Mercuri NB, Schirinzi T. Adult-onset sporadic chorea: real-world data from a single-centre retrospective study. Neurol Sci. 2021 May 26. DOI: 10.1007/s10072-021-05332-w
  10. 10Meneret A, Garcin B, Frismand S, Lannuzel A, Mariani L, Roze E. Treatable Hyperkinetic Movement Disorders Not to Be Missed. Front Neurol. 2021; 12: 659805. DOI: 10.3389/fneur.2021.659805
  11. 11Castilhos RM, Souza AF, Furtado GV, Gheno TC, Silva AL, Vargas FR, Lima MA, Barsottini O, Pedroso JL, Godeiro C Jr., Salarini D, Pereira ET, Lin K, Toralles MB, Saute JA, Rieder CR, Quintas M, Sequeiros J, Alonso I, Saraiva-Pereira ML, Jardim LB. Huntington disease and Huntington disease-like in a case series from Brazil. Clin Genet. 2014; 86(4): 3737. DOI: 10.1111/cge.12283
  12. 12Kenney C, Powell S, Jankovic J. Autopsy-proven Huntington’s disease with 29 trinucleotide repeats. Mov Disord 2007. 22(1): 127130. DOI: 10.1002/mds.21195
  13. 13Ha AD, Beck CA, Jankovic J. Intermediate CAG Repeats in Huntington’s Disease: Analysis of COHORT. Tremor Other Hyperkinet Mov (N Y). 2012; 2: tre-02-64-287-4. DOI: 10.5334/tohm.85
  14. 14Garcia-Ruiz PJ, Garcia-Caldentey J, Feliz C, del Val J, Herranz A, Martínez-Castrillo JC. Late onset Huntington’s disease with 29 CAG repeat expansion. J Neurol Sci. 2016; 363: 1145. DOI: 10.1016/j.jns.2016.02.030
  15. 15Savitt D, Jankovic J. Clinical phenotype in carriers of intermediate alleles in the huntingtin gene. J Neurol Sci. 2019; 402: 5761. DOI: 10.1016/j.jns.2019.05.010
  16. 16Jevtic S, Provias JP. Case report and literature review of Huntington disease with intermediate CAG expansion. BMJ Neurol open. 2020 Feb 9; 2(1): e000027. eCollection 2020. DOI: 10.1136/bmjno-2019-000027
  17. 17Garcia Ruiz PJ, Ayerbe J, Bader B, Danek A, Sanz MJ, Cabo I, Alonso Frech F. Deep brain stimulation in chorea acanthocytosis. Mov Disord 2009. 24(10): 15467. DOI: 10.1002/mds.22592
  18. 18Vijiaratnam N, Bhatia KP, Lang AE, Raskind WH, Espay AJ. ADCY5-Related Dyskinesia: Improving Clinical Detection of an Evolving Disorder. Mov Disord Clin Pract. 2019; 6(7): 512520. DOI: 10.1002/mdc3.12816
  19. 19Hallett M, Kaufman C. Physiological observations in Sydenham’s chorea. Neurol Neurosurg Psychiatry 1981. 44(9): 82932. DOI: 10.1136/jnnp.44.9.829
  20. 20Cardoso F. Sydenham’s chorea. Handb Clin Neurol. 2011; 100: 2219. DOI: 10.1016/B978-0-444-52014-2.00014-8
  21. 21Orsini A, Foiadelli T, Magistrali M, Carli N, Bagnasco I, Dassi P, Verrotti A, Marcotulli D, et al. A nationwide study on Sydenham’s chorea: Clinical features, treatment and prognostic factors. Eur J Paediatr Neurol. 2022; 36: 16. DOI: 10.1016/j.ejpn.2021.11.002
  22. 22Baizabal-Carvallo JF, Alonso-Juarez M, Koslowski M. Chorea in systemic lupus erythematosus. J Clin Rheumatol. 2011; 17: 6972. DOI: 10.1097/RHU.0b013e31820e7c8d
  23. 23Delorme C, Cohen F, Hubsch C, Roze Ev. Chorea as the initial manifestation of Sjogren syndrome. Pediatr Neurol. 2015; 52(6): 6478. DOI: 10.1016/j.pediatrneurol.2015.02.021
  24. 24Alvarado-Franco NL, Gonzalez-Marques C, Olguín-Ramírez LA, Garza-Alpirez A, Femat-Roldan G, Martinez-Ramirez D. Athetoid Movements as Initial Manifestation of Primary Sjögren Syndrome. Tremor Other Hyperkinet Mov (N Y). 2018 Aug 16; 8: 573. DOI: 10.5334/tohm.419
  25. 25Nomura M, Okada J, Tateno S, Kobayashi Y, Kondo H. Renal thrombotic microangiopathy in a patient with rheumatoid arthritis and antiphospholipid syndrome: successful treatment with cyclophosphamide pulse therapy and anticoagulant. Intern Med. 1994; 33(8): 4847. DOI: 10.2169/internalmedicine.33.484
  26. 26Suchowersky O, Muthipeedika J. A case of lateonset chorea. Nat Clin Pract Neurol. 2005; 1(2): 1136. DOI: 10.1038/ncpneuro0052
  27. 27Patel RA, Hall DA, Eichenseer S, Bailey M. Movement disorders and hematological diseases. Mov Disord Clin Pract. 2020; 8(2): 193207. DOI: 10.1002/mdc3.13129
  28. 28Jiménez-Jiménez FJ, García-Ruiz PJ, Molina JA. Drug-induced movement disorders. Drug Saf. 1997; 16(3): 180204. DOI: 10.2165/00002018-199716030-00004
  29. 29Waln O, Jankovic J. An update on tardive dyskinesia: from phenomenology to treatment. Tremor Other Hyperkinet Mov (N Y). 2013; 3: tre-03-161-4138-1. DOI: 10.5334/tohm.165
  30. 30Gatto EM, Aldinio V, Parisi V, Persi G, Da Prat G, Bullrich MB, Sanchez P, Rojas G. Sertraline-induced Hemichorea. Tremor Other Hyperkinet Mov (N Y). 2017 Dec 18; 7: 518. DOI: 10.5334/tohm.367
  31. 31Martin EJ, Vaughan CL, Atayee R, Hirst JM, O’Donnell K, Edmonds KP. Hydromorphone-induced chorea as an atypical presentation of opioid neurotoxicity: A case report and review of the literature. Palliat Med. 2018 Oct; 32(9): 15291532. DOI: 10.1177/0269216318786861
  32. 32Forbes E, Vaswani PA, Duda JE, Morley JF. Uremic Striatopallidal Syndrome Manifesting as Acute Onset Chorea. Mov Disord Clin Pract. 2021; 8(Suppl 1): S55-S57. DOI: 10.1002/mdc3.13285
  33. 33Hamed S, Mohamed K, Abd Elhameed S, Moussa E, Abozaid H, Lang A, Mohamed A, Moussa J. Movement Disorders Due to Selective Basal Ganglia Lesions with Uremia. Can J Neurol Sci. 2020; 47(3): 350365. DOI: 10.1017/cjn.2020.29
  34. 34Manickavasigar R, Chemmanam T, Youssef A, Agarwal A, Prentice DA, Irish AB. The Extrapyramidal Syndromes of Chronic Kidney Disease and Dialysis (EPS-CKDD): diagnostic criteria, risk factors and prognosis. QJM. 2021 May 19; hcab140. DOI: 10.1093/qjmed/hcab140
  35. 35Sousa AL, Salgado P, Alves JE, Silva S, Ferreira S, Magalhães M. Uncommon Movement Disorders in Chronic Hepatic Disease with Response to Rifaximin. Tremor Other Hyperkinet Mov (N Y). 2019 Aug 2; 9. DOI: 10.5334/tohm.475
  36. 36Ryan C, Ahlskog JE, Savica R. Hyperglycemic chorea/ballism ascertained over 15 years at a referral medical center. Parkinsonism Relat Disord. 2018; 48: 97100. DOI: 10.1016/j.parkreldis.2017.12.032
  37. 37Cosentino C, Torres L, Nuñez Y, Suarez R, Velez M, Flores M. Hemichorea/Hemiballism Associated with Hyperglycemia: Report of 20 Cases. Tremor Other Hyperkinet Mov (N Y). 2016 Jul 19; 6: 402. DOI: 10.5334/tohm.291
  38. 38Chua CB, Sun CK, Hsu CW, Tai YC, Liang CY, Tsai IT. “Diabetic striatopathy”: clinical presentations, controversy, pathogenesis, treatments, and outcomes. Sci Rep. 2020 Jan 31; 10(1): 1594. DOI: 10.1038/s41598-020-58555-w
  39. 39Lee MS, Marsden CD. Movement disorders following lesions of the thalamus or subthalamic region. Mov Disord. 1994; 9(5): 493507. DOI: 10.1002/mds.870090502
  40. 40Alarcón F, Zijlmans JCM, Dueñas G, Cevallos N. Post-stroke movement disorders: report of 56 patients. J Neurol Neurosurg Psychiatry. 2004; 75(11): 156874. DOI: 10.1136/jnnp.2003.011874
  41. 41Mehanna R, Jankovic J. Movement disorders in cerebrovascular disease. Lancet Neurol. 2013; 12(6): 597608. DOI: 10.1016/S1474-4422(13)70057-7
  42. 42Gonzalez-Usigli H, Espay AJ. Teaching Video NeuroImages: semiology and localization of ballistic movements. Neurology. 2014 Jul 22; 83(4): e567. DOI: 10.1212/WNL.0000000000000622
  43. 43Suri R, Rodriguez-Porcel F, Donohue K, Jesse E, Lovera L, Dwivedi AK, Espay AJ. Post-stroke Movement Disorders: The Clinical, Neuroanatomic, and Demographic Portrait of 284 Published Cases. J Stroke Cerebrovasc Dis. 2018; 27(9): 23882397. DOI: 10.1016/j.jstrokecerebrovasdis.2018.04.028
  44. 44Carbayo A, Sarto J, Santana D, Compta Y, Urra X. Hemichorea as Presentation of Acute Cortical Ischemic Stroke. Case Series and Review of the Literature. J Stroke Cerebrovasc Dis. 2020 Oct; 29(10): 105150. DOI: 10.1016/j.jstrokecerebrovasdis.2020.105150
  45. 45Schreglmann SR, Riederer F, Galovic M, Ganos C, Kägi G, Waldvogel D, Jaunmuktane Z, Schaller A, Hidding U, Krasemann E, Michels L, Baumann CR, Bhatia K, Jung HH. Movement disorders in genetically confirmed mitochondrial disease and the putative role of the cerebellum. Mov Disord. 2018; 33(1): 146155. DOI: 10.1002/mds.27174
  46. 46Monbaliu E, de Cock P, Ortibus E, Heyrman L, Klingels K, Feys H. Clinical patterns of dystonia and choreoathetosis in participants with dyskinetic cerebral palsy. Dev Med Child Neurol. 2016; 58(2): 13844. DOI: 10.1111/dmcn.12846
  47. 47Monbaliu E, Himmelmann K, Lin JP, Ortibus E, Bonouvrié L, Feys H, Vermeulen RJ, Dan B. Clinical presentation and management of dyskinetic cerebral palsy. Lancet Neurol. 2017; 16(9): 741749. DOI: 10.1016/S1474-4422(17)30252-1
  48. 48Pearson TS, Pons R, Ghaoui R, Sue CM. Genetic mimics of cerebral palsy. Mov Disord. 2019; 34(5): 625636. DOI: 10.1002/mds.27655
  49. 49Moioli A, Maresca B, Manzione A, Napoletano AM, Coclite D, Pirozzi N, Punzo G, Menè P. Metformin associated lactic acidosis (MALA): clinical profiling and management. J Nephrol. 2016; 29(6): 783789. DOI: 10.1007/s40620-016-0267-8
  50. 50Scott BL, Jankovic J. Delayed-onset progressive movement disorders after static brain lesions. Neurology. 1996; 46(1): 6874. DOI: 10.1212/WNL.46.1.68
  51. 51Krauss JK. Movement disorders secondary to craniocerebral trauma. Handb Clin Neurol. 2015; 128: 47596. DOI: 10.1016/B978-0-444-63521-1.00030-3
  52. 52Manjunath N, Jhunjhunwala K, Devi BI, Pal PK. Posttraumatic movement disorders: A clinical and imaging profile of 30 patients. Neurol India. 2019; 67(3): 738743.
  53. 53Moon D. Disorders of Movement due to Acquired and Traumatic Brain Injury. Curr Phys Med Rehabil Rep. 2022; 10(4): 311323. DOI: 10.1007/s40141-022-00368-1
  54. 54Nielsen TR, Bruhn P, Nielsen JE, Hjermind LE. Behavioral variant of frontotemporal dementia mimicking Huntington’s disease. Int Psychogeriatr. 2010; 22(4): 6747. DOI: 10.1017/S1041610210000098
  55. 55Baizabal-Carvallo JF, Jankovic J. Parkinsonism, movement disorders and genetics in frontotemporal dementia. Nat Rev Neurol. 2016; 12(3): 17585. DOI: 10.1038/nrneurol.2016.14
  56. 56Schneider SA, Bird T. Huntington’s Disease, Huntington’s Disease Look-Alikes, and Benign Hereditary Chorea: What’s New? Mov Disord Clin Pract. 2016 27; 3(4): 342354. DOI: 10.1002/mdc3.12312
  57. 57Estevez-Fraga C, Magrinelli F, Hensman Moss D, Mulroy E, Di Lazzaro G, Latorre A, Mackenzie M, Houlden H, Tabrizi SJ, Bhatia KP. Expanding the Spectrum of Movement Disorders Associated With C9orf72 Hexanucleotide Expansions. Neurol Genet. 2021 Mar 12; 7(2): e575. DOI: 10.1212/NXG.0000000000000575
  58. 58Ramos EM, Dokuru DR, Van Berlo V, Wojta K, Wang Q, Huang AY, Deverasetty S, Qin Y, van Blitterswijk M, et al. ARTFL/LEFFTDS consortium, Coppola G. Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases. Alzheimers Dement. 2020; 16(1): 118130. DOI: 10.1002/alz.12011
  59. 59Kumar N, Rizek P, Sadikovic B, Adams PC, Jog M. Movement disorders associated with hemochromatosis. Can J Neurol Sci 2016. 43(6): 801808. DOI: 10.1017/cjn.2016.286
  60. 60Russo N, Edwards M, Andrews T, O’Brien M, Bhatia KP. Hereditary haemochromatosis is unlikely to cause movement disorders—a critical review. J Neurol. 2004; 251(7): 84952. DOI: 10.1007/s00415-004-0445-9
DOI: https://doi.org/10.5334/tohm.800 | Journal eISSN: 2160-8288
Language: English
Submitted on: Jul 12, 2023
Accepted on: Aug 24, 2023
Published on: Sep 7, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2023 Pedro J. Garcia Ruiz, Lola Diaz Feliz, Cici E. Feliz, Isabel Lorda Sanchez, Almudena Avila Fernandez, Fiona Blanco Kelly, Maria Jose Trujillo Tiebas, Javier del Val, Inma Navas Vinagre, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.